AdaptHealth Corp. AHCO
7.33 USD -0.08 (-1.08%)
At closeNov 6, 2026, 4:00 PM EST
7.33 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
7.11 Day range 7.49
5.21 52-week range 13.43
- YTD
- -26.41%
- 1 year
- -23.73%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 8.71 +18.9% upside
Now 7.33
- Target (low)
- 7.00
- Target (mean)
- 8.71
- Target (high)
- 10.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy1
- Buy6
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
- 3 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.055 | -0.12 – -0.01 | 0.2689 | -120.4% | 716.96M | -15.3% | 4 |
| Next quarter | -0.12 | -0.12 – -0.12 | -0.0501 | -139.5% | 748.39M | -8.7% | 2 |
| Current year | -0.495 | -1.46 – -0.10 | 0.5428 | -191.2% | 2.91B | -10.4% | 4 |
| Next year | -0.18 | -0.24 – -0.03 | -0.495 | +63.6% | 3.01B | +3.6% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 5, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Nov 4, 2026 | UBS | Maintained | Buy | Buy |
| Sep 17, 2026 | Baird | Maintained | Outperform | Outperform |
| Aug 6, 2026 | UBS | Maintained | Buy | Buy |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 5, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 21, 2026 | Jefferies | Upgrade | Hold | Buy |
| Jul 6, 2026 | Baird | Maintained | Outperform | Outperform |
| May 11, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 6, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 6, 2026 | UBS | Maintained | Buy | Buy |
| Apr 13, 2026 | Truist Securities | Maintained | Buy | Buy |
| Feb 26, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Nov 6, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| May 12, 2025 | Truist Securities | Maintained | Buy | Buy |
| May 8, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 27, 2025 | Baird | Maintained | Outperform | Outperform |
| Feb 26, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 26, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 26, 2025 | Truist Securities | Maintained | Buy | Buy |
| Feb 13, 2025 | UBS | Maintained | Buy | Buy |
| Nov 19, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 15, 2024 | Truist Securities | Maintained | Buy | Buy |
| Nov 6, 2024 | UBS | Maintained | Buy | Buy |
| Nov 6, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Nov 6, 2024 | Baird | Maintained | Outperform | Outperform |
| Aug 12, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| May 15, 2024 | Truist Securities | Maintained | Buy | Buy |
| Mar 4, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Feb 28, 2024 | UBS | Maintained | Buy | Buy |
